A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07628855 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07628855
- Sponsor
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-14
- Primary completion
- 2028-08-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.